MyFinsight
Home
Blog
About
Contact
Download
Download image
US
$327,800K
Non Us
$44,600K
Revenue From Contract
With Customer...
$186,300K
Revenue From Contract
With Customer...
$144,100K
US
$109,800K
Non Us
$11,900K
Net loss
-$365,900K
(-187.43%↓ Y/Y)
Income tax (benefit)
expense
-$29,200K
(-868.42%↓ Y/Y)
Hereditary Cancer
$372,400K
Prenatal
$186,300K
Mental Health
$144,100K
Tumor Profiling
$121,700K
Loss before income
tax
-$395,100K
(-219.92%↓ Y/Y)
Revenue
$824,500K
(-1.56%↓ Y/Y)
Operating loss
-$387,200K
(-213.52%↓ Y/Y)
Total other expense
-$7,900K
Gross profit
$576,600K
(-1.50%↓ Y/Y)
Interest income
$1,800K
(5.88%↑ Y/Y)
Other
$800K
(-27.27%↓ Y/Y)
Cost of revenue
$247,900K
(-1.70%↓ Y/Y)
Total operating
expenses
$963,800K
(35.96%↑ Y/Y)
Interest expense
$10,500K
(275.00%↑ Y/Y)
Goodwill and long-lived
asset impairment...
$319,400K
(462.32%↑ Y/Y)
Sales and marketing
expense
$280,800K
(-1.16%↓ Y/Y)
General and
administrative expense
$256,800K
(-6.92%↓ Y/Y)
Research and development
expense
$106,800K
(-5.82%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
MYRIAD GENETICS INC (MYGN)
MYRIAD GENETICS INC (MYGN)